Author: therawinformant

Stocks go up, stocks go down, you can't explain that…Or maybe you can, if the stock happen to be a biotech that just flunked a clinical trial. Which leads us nicely to Celsion Corporation (CLSN). Or not so nicely if you happen to be an investor.Shares cratered by a dispiriting 68% this week after the company announced that the independent Data Monitoring Committee (DMC) recommended it prematurely bring to an end its Phase 3 OPTIMA study evaluating ThermoDox in patients with primary liver cancer.Based on an interim safety and efficacy analysis, the DMC concluded the study was unlikely to achieve the primary endpoint after exceeding a futility threshold value.With Celsion still assessing the data, management have outlined 3 possible paths forward: “1) continuation of the study through final analysis, 2) discontinuation of the study for futility, and lastly 3) assessment of the study following some additional events (n=8–10).”For Oppenheimer analyst Hartag Singh, the well-designed study’s results were obviously “disappointing.”Although the analyst points out that Celsion management has indicated “a potential preference for the (inexpensive) third option,” it is doubtful the outcome will be any different.With ThermoDox likely to be discarded, attention will now turn to GEN-1, the biotech’s treatment for ovarian cancer – a notoriously hard to treat disease. GEN-1 has shown promise in the first part of a phase 1/2 trial and has been given the go ahead to continue with the second portion, which will be initiated in August. While it is still early days, Singh is piqued by the reaction to the initial data.The 5-star analyst said, “While we expect to see more on GEN-1, particularly as the Phase 2 program initiates in August, work may lay ahead on the manufacturing front, and we await a broader data set. Nonetheless, initial results have been intriguing: a 2x higher R0 resection rate in newly-diagnosed Stage III/IV ovarian cancer (over historical) generating significant physician enthusiasm for the approach.”However, for now, along with removing ThermoDox from his Celsion model, Singh drops his rating from Outperform (i.e. Buy) to Perform (i.e. Hold) and takes his price target off the table. (To watch Singh’s track record, click here)Overall, two other analysts recently reviewed Celsion’s prospects, one saying Buy, while the other suggesting Hold. (See Celsion stock analysis on TipRanks)To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights. More recent articles from Smarter Analyst: * $1000 Is the Number to Watch for Shopify Stock, Says 5-Star Analyst * Q2 Semiconductor Preview: What to Expect * Oppenheimer: These 2 "Strong Buy" Stocks Are Poised to Surge by Over 80% * Dynavax Teams Up With Mt Sinai On Universal Flu Vaccine

from Yahoo Finance https://ift.tt/2CmbmeQ

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each stock might be going. […]

from Yahoo Finance https://ift.tt/2WtnzVY

One of the relics of the global financial crisis is that the notion of long-term stocks was dead. Back then, many experts said investors needed to become more nimble going forward or risk being exposed when the next crisis hit.Thing is from the March 10, 2009, market bottom through July 10, 2020, the SPDR S&P 500 ETF (NYSEARCA:SPY) jumped 456%. That time frame certainly qualifies as "long term" and includes an array of pitfalls for riskier assets. These include the European sovereign debt crisis, the taper tantrum, a trade war with China and the March 2020 slide at the hands of the novel coronavirus.That SPY performance is proof positive long-term investing isn't, but what does change over time are the names that qualify as the best long-term stocks. I'm going to use Coca-Cola (NYSE:KO). For generations, the world's largest soft drink maker would have qualified as a great "set it and forget it" stock.InvestorPlace – Stock Market News, Stock Advice & Trading TipsI'm bringing up Coca-Cola because recently, I saw some folks on Twitter saying the stock only delivered returns of 3% over the past 22 years. Initially, I didn't believe it. Sure enough, it's true. Worse yet, an investor that bought Coca-Cola in 1998 would have been down 50% a decade later and needed 15 years just to get back to even. That's not best long-term stock status. * 15 Growth Stocks That Are Being Propped Up By Low RatesGood news is there are some names out there today that could be sound set it and forget ideas. Here are a few to consider. * Microsoft (NASDAQ:MSFT) * Mastercard (NYSE:MA) * Johnson & Johnson (NYSE:JNJ) Best Long-Term Stocks: Microsoft (MSFT)Source: VDB Photos / Shutterstock.com By constructing this list in 2020, it's almost impossible to leave Microsoft off and not simply because this is the largest domestic company by market capitalization. The company is firing on all cylinders today. And, while MSFT stock is up 49% over the past year, the name is buoyed by an array of positive fundamental factors.First, a brief history lesson. Microsoft is 45 years old and went public in 1986. At a time when so many investors are smitten with shiny new objects, those factoids could be construed as strikes against Microsoft. Actually, the opposite is true because this middle-aged company is showing it's adaptable and has levers for growth.Microsoft is the second-largest cloud computing company, an impressive feat when considering the company didn't even enter that business until 2020. Today, the Azure unit is one of the fastest-growing cloud computing entities on the market, confirming Microsoft can enter a competition late and still scale its way to dominance.Adding to the case for Microsoft as one of the best long-term ideas is adaptability nurtured under the stewardship of CEO Satya Nadella. For example, core products such as Microsoft Office 365 used to be sold on a one-off basis. Now, Microsoft runs a more lucrative subscription model. This makes revenue visibility easier to ascertain – a favorable trait for long-term investors.The combination of strong leadership, a fortress balance sheet and leadership in some trends that are becoming secular tailwinds make MSFT stock an ideal long-term holding for investors of varying demographics and risk tolerances. Mastercard (MA)Source: Alexander Yakimov / Shutterstock.com Like Microsoft, Mastercard is classified as a technology stock, though investors often view it through a financial services lens. Put those two concepts together and you've got fintech, as known as the way of accessing growth in the financial services arena.There are more nimble, growthier fintech names than Mastercard to consider, such as PayPal (NASDAQ:PYPL) and Square (NYSE:SQ). That pair is positioned for long-term success, too. Mastercard is included here because it's less volatile than those fintech names, meaning its drawdowns over long holding periods should be less severe.Obviously, a big part of the long-term fintech thesis is the move away from cash to card and digital payments, a trend Mastercard stands to benefit from. Importantly, cards only recently surpassed cash as the world's primary payment option. This indicates the cashless trend is still in its early innings.An important feather in the cap of Mastercard is that, like other beloved companies in other industries, it's able to leverage the network effect. This is a fancy way of saying Mastercard is able to effectively monetize users even though those customers aren't directly paying the company. * 15 Growth Stocks That Are Being Propped Up By Low Rates"Payment networks such as Mastercard benefit, unsurprisingly, from a network effect," notes Morningstar. "The more consumers that are plugged into a payment network, the more attractive that payment network becomes for merchants, which, in turn, makes the network more convenient for consumers and so on." Johnson & Johnson (JNJ)Source: Alexander Tolstykh / Shutterstock.com Johnson & Johnson is the oldest and sleepiest of the stocks highlighted here and it's far from glamorous relative to other healthcare names. Those aren't knocks on JNJ and those traits don't mean this stock will succumb to the aforementioned woes of Coca-Cola. Plus, JNJ has some potential for excitement due to its participation in the Covid-19 vaccine race.JNJ isn't a growth biotechnology stock. It is able to source growth through its medical devices division, which puts the company at the corner of one of the healthcare sector's more compelling growth segments.Owing in large part to an aging population, "the United States remains the largest medical device market in the world: $156 billion (40 percent of the global medical device market in 2017). By 2023, it is expected to grow to $208 billion," according to SelectUSA.JNJ is able to take some of the sting out of the pitfalls associated with the pharmaceuticals business, including patent cliffs and failed trails. The company's strengths include its consumer products business, strong balance sheet and a dividend increase streak that spans multiple decades.Todd Shriber has been an InvestorPlace contributor since 2014. As of this writing, he did not hold a position in any of the aforementioned securities. More From InvestorPlace * Why Everyone Is Investing in 5G All WRONG * America's 1 Stock Picker Reveals His Next 1,000% Winner * Revolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 Company * Radical New Battery Could Dismantle Oil Markets The post 3 Best Long-Term Stocks to Set and Forget appeared first on InvestorPlace.

from Yahoo Finance https://ift.tt/2OF1NKI

Michael Jones, Caravel Concepts Chairman and CEO, joins Yahoo Finance’s The First Trade with Alexis Christoforous and Brian Sozzi to discuss what’s moving the markets on Friday morning.

from Yahoo Finance https://ift.tt/2Wudgkp

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […]

from Yahoo Finance https://ift.tt/398G5bv

Brown Advisory recently released its Q2 2020 Investor Letter, a copy of which you can download here. The Equity Income Fund posted a return of 18.29% for the quarter, underperforming its benchmark, the S&P 500 Index which returned 20.55% in the same quarter. You should check out Brown Advisory’s top 5 stock picks for investors […]

from Yahoo Finance https://ift.tt/2Wtc3tI

Right now the markets are facing down high unemployment and business closures, with a health crisis added to the mix. It's safe to say that this was not a good year for the American economy — and specifically not for banks. With interest rates close to zero, large bank stocks saw some of their biggest price drops in decades.There were some macro developments in the economy, such as the fall in unemployment rates each month as businesses begin to open up. However, the banking industry continues to remain one of the more befuddling sectors as corporations face the risk of loans gone bad and low interest rates.Companies kicked off earnings season this week and bank stocks saw some volatility on Tuesday in anticipation of the results. JP Morgan (NYSE:JPM) shares rose 0.6% while Wells Fargo (NYSE:WFC) stock dropped 4.6%, among others.InvestorPlace – Stock Market News, Stock Advice & Trading Tips * 15 Growth Stocks That Are Being Propped Up By Low Rates However, speculations were soon put to rest when earnings were released. Based on the results, here are three stocks still worth a look: * Goldman Sachs (NYSE:GS) * JP Morgan * Citigroup (NYSE:C) Bank Stocks: Goldman Sachs (GS)Source: Volodymyr Plysiuk / Shutterstock.com If we were to crown a winner of the bank earnings season (thus far), it would have to be Goldman Sachs. In the hours prior to market open on July 15, the company released its earnings report and the numbers were a smashing success.Tensions ran high for many banks into earnings season but the same cannot be said for Goldman Sachs — it saw some of its best revenue in years. According to CNBC, the bank's revenue for the period was $13.3 billion which beat estimates by over $3.5 billion. Earnings per share (EPS) was not too shabby at $6.26 per share, which eclipsed the estimated $3.78 per share.There were a lot of shining stars in Goldman's earnings this year. These include a global markets division that secured $7.2 billion in revenue, asset management division that brought in $2.1 billion and investment banking with a $2.7 billion on the table.In terms of credit reserves, the company had $1.59 billion in its back pocket, but this wasn't enough as profits fell by 33%. However, this is hardly a cause for concern for investors, given the stellar revenue numbers across all operations.Goldman Sachs' strong performance can be attributed to two main drivers. The first is activities on Wall Street, like trading and banking. Customers' low-value deposits in retail banking have been a boon for the company's stock price. This was in tandem with market volatility that led many investors to hedge their losses and place risky bets.The second comes in the form of a fiscal stimulus from the government. The effect of the pandemic was detrimental to the economy's performance and the government did everything in its power to keep the credit markets afloat. The aggressive stimulus injected by the central bank enabled Goldman's currency and commodity market numbers to hit a record high.Nevertheless, we are only halfway through the year and analysts expect to see a fall in trading revenue in the second half. According to Goldman's CEO, David Solomon, the earnings are a testament to the company's diverse business model and although trading revenue has slowed down, it still remains at a "heightened level of activity." JP Morgan (JPM)Source: Bjorn Bakstad / Shutterstock.com Although the pandemic weighed heavily on the bank stocks, JP Morgan was able to put up some surprising results in this period. The company shattered analyst expectations with a high trading revenue that was aided by strong market volatility.According to a report by CNBC, JP Morgan posted earnings for this period at $1.38 per share, which was higher than the estimated $1.04 as per analyst estimates. As for revenue, the company earned an adjusted revenue of $33 billion in comparison to the expected $30.3 billion. The numbers provide a healthy cushion for the bank to sustain its dividends.JP Morgan's strong bottom line comes from its high trading revenue, which was up 79% in a year-over-year comparison. The bank also boasts a strong loss-absorbing capability thanks to a large credit reserve. According to its CEO, Jamie Dimon, JP Morgan has a liquidity of $1.5 trillion and $34 billion in credit reserves.However, the earnings call did have its low points. JP Morgan reported a loss of $176 million in its retail banking division which was significantly lower than the $4.6 billion profit last quarter. However, the bank's $8.9 billion set aside for its corona-induced troubles helped offset some of these losses.But despite the better-than-expected numbers, Dimon urged caution about the bank's future. He stated that the myriad of uncertainties that exist in the second half of the year could set back optimistic returns this period. This skepticism comes after governments have reversed the course of reopening in many states. * 7 Cybersecurity Stocks Perfect for Securing Your Portfolio Nevertheless, Dimon is optimistic that JP Morgan's "fortress balance sheet" is prepared to overcome what may come its way. In the coming months, investors can expect to see greater swings in this stock as the future of the banking sector is driven by the progression of the pandemic — for better or for worse. Citigroup (C)Source: TungCheung / Shutterstock.com Another bank stocks earnings call that came as a pleasant surprise and beat estimates is Citigroup. Like JP Morgan, the bank's earnings were also aided by its fixed-income trading revenue. However, it did sustain losses in some divisions.According to Business Insider, the company reported a net income of $1.3 billion for the earnings period which was 73% lower in a year over year comparison. However, the EPS was 50 cents, which was higher than the expected 38 cents per share. Revenue was also higher, at $19.8 billion, which beat the forecasted $19.2 billion.Citigroup's revenue surge comes after the sharp volatility in the markets as a result of the pandemic. The bank also received a fiscal stimulus from the government that helped soften the blow of its losses. The revenue from fixed income markets was 68% higher while investment banking revenue saw a spike of 37%.However, the company's earnings weren't entirely rosy. Citigroup suffered a credit crisis that hurt its numbers. One of the biggest divisions that was hurt as a result of the pandemic was consumer banking as customers defaulted on loans and credit card payments. This problem was reflected in Citigroup's numbers.The bank's total allowance for credit losses (ACL) for the period was a whopping $26.4 billion, well more than just $12.5 billion in the year-ago quarter. The ACL is the amount of money the bank puts aside for debts that it is unlikely to recover. The increased allowance rate comes as a result of customers' inability to repay loans. Total net credit losses were 12% higher compared to the previous year.Despite the high credit costs, the company's CEO, Michael Corbat, is confident of Citigroup's strength to weather the Covid-19 storm. Moving forward, the company will focus its efforts on risk management in order to prepare for the future. The pandemic has created an onslaught of uncertainty for most major banks but Citigroup has emerged relatively unscathed.While the future of the company is still up in the air, Citigroup's current earnings has restored a sliver of confidence in investors. This bank stock is definitely worth a second look.Divya Premkumar has a finance degree from the University of Houston, Texas. She is a financial writer and analyst who has written stories on various financial topics from investing to personal finance. Divya has been writing for Investor Place since 2020. As of this writing, Divya Premkumar did not own any of the aforementioned stocks. More From InvestorPlace * Why Everyone Is Investing in 5G All WRONG * America's 1 Stock Picker Reveals His Next 1,000% Winner * Revolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 Company * Radical New Battery Could Dismantle Oil Markets The post These 3 Bank Stocks Are Still Worth a Look appeared first on InvestorPlace.

from Yahoo Finance https://ift.tt/3fIxxul

I have to admit, there's something to be said for Luckin Coffee (OTCMKTS:LKNCY). The company has had an accounting scandal involving millions of fraudulent transactions. That scandal caused the removal of its CEO. As a bonus, Luckin stock dropped so low it was delisted.Source: Keitma / Shutterstock.com And yet, like a phoenix rising from the ashes, Luckin stock continues to draw the attention of traders. Since beginning to trade again in May, shares have more than doubled and been more than cut in half. My InvestorPlace colleague, Mark Hake, makes a reasonable case that shares of Luckin stock may be priced just about right.But then again, Hake acknowledges his back of the envelope math is not based on full information. At the time of this writing, the company has not yet offered a date for the release of its earnings. And that should give investors a bit of concern. Because right now, it doesn't look like much has changed for Luckin.InvestorPlace – Stock Market News, Stock Advice & Trading Tips The New CEO Is…the Old CEO?To move on from its accounting scandal, Luckin needs to avoid even the appearance of impropriety, right? Maybe not. * 15 Growth Stocks That Are Being Propped Up By Low Rates In June, Haode Investments called a meeting for July 5. The purpose of the meeting was to vote off Chairman Charles Lu and three other Luckin board members. Haode Investments holds Luckin shares that Lu owns. So why would Lu allow a meeting to be called so he could be voted out?Lu has repeatedly denied involvement in the scandal. However, he reportedly refused to hand over his laptop and phone as part of the company's internal investigation. So it has to raise eyebrows that as part of the July 5 purge, the head of the internal investigation was also voted off the board.And Lu has apparently replaced the other two board members with his hand-picked representatives. Which means it's likely that Lu is still calling the shots from behind the scenes. China Is Not a Coffee CultureI've made this argument in a previous article about Luckin. The bullish argument is that young people love technology. China has a gigantic market of youths. The company has a "grab and go" model that allows customers to order via the app and then pick up their coffee at one of the over 6,000 stores the company operates throughout China.It's a sound model that has caught the attention of Starbucks (NASDAQ:SBUX). The coffee giant is taking some cues from Luckin in trying to compete with Luckin's lower priced offering.But there's a reason there's an idiom about "all the tea in China." China has an established, deeply rooted tea culture. Coffee? Not so much.I wrote about this cultural barrier in June:According to research from the University of Southern California, per capita coffee consumption in China is just five cups a year. That's not a misprint. In the U.S., per capita is 400 cups a year. And in some European countries that number can exceed 1,000 cups a year.I have had concerns about Nio (NYSE:NIO) investors in the past for a different logic problem.The narrative was that electric cars were popular in China. Therefore, Nio as a Chinese company would be a great investment. And while it's true that Nio has made strides, for a time they were in danger of running out of cash.But the point of that example is that Nio is leaning into an established market that has a high cost of entry to keep out competitors. Luckin is trying to compete in a market that even Starbucks is finding challenging because of the expanding competition.In short, there are a lot of companies chasing a group of customers that may be smaller than it seems. Luckin Stock Has a Lot to ProveRight now, it's probably fashionable to be negative about Chinese stocks. Luckin may turn out to be a success story. But I have concerns. Right now, despite an opportunity for a new lease on life, Luckin appears to be simply making cosmetic changes.Until I see some actual sales figures from the company, Luckin remains a hard pass for me.Chris Markoch is a freelance financial copywriter who has been covering the market for over five years. He has been writing for InvestorPlace since 2019. As of this writing, Chris Markoch did not hold a position in any of the aforementioned securities. More From InvestorPlace * Why Everyone Is Investing in 5G All WRONG * America's 1 Stock Picker Reveals His Next 1,000% Winner * Revolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 Company * Radical New Battery Could Dismantle Oil Markets The post Only the Names Have Changed for Luckin Coffee appeared first on InvestorPlace.

from Yahoo Finance https://ift.tt/2CLGW5F